Humira’s dominance continues as the world’s top-selling prescription product as the biologic therapy is the first drug to exceed $20 billion in annual global sales.
https://www.pharmalive.com/wp-content/uploads/2016/08/Humira-Pen.jpg151300Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2019-08-11 22:50:532020-05-01 15:11:36Top 200 Medicines Annual Report 2019: The king of medicines